Although ethnic factors on drug responses should be taken into consideration, the finding of increased risk of liver dysfunction with ACE inhibitors in Japanese patients provide valuable insights into their safety profile and appropriate clinical use. The gene discussed is ACE; the disease is Decreased liver function.